187 related articles for article (PubMed ID: 22552584)
1. TLR3 dsRNA agonist inhibits growth and invasion of HepG2.2.15 HCC cells.
Chen L; Xu YY; Zhou JM; Wu YY; E Q; Zhu YY
Oncol Rep; 2012 Jul; 28(1):200-6. PubMed ID: 22552584
[TBL] [Abstract][Full Text] [Related]
2. Double-stranded RNA-induced TLR3 activation inhibits angiogenesis and triggers apoptosis of human hepatocellular carcinoma cells.
Guo Z; Chen L; Zhu Y; Zhang Y; He S; Qin J; Tang X; Zhou J; Wei Y
Oncol Rep; 2012 Feb; 27(2):396-402. PubMed ID: 22075935
[TBL] [Abstract][Full Text] [Related]
3. Dual topology of functional Toll-like receptor 3 expression in human hepatocellular carcinoma: differential signaling mechanisms of TLR3-induced NF-kappaB activation and apoptosis.
Yoneda K; Sugimoto K; Shiraki K; Tanaka J; Beppu T; Fuke H; Yamamoto N; Masuya M; Horie R; Uchida K; Takei Y
Int J Oncol; 2008 Nov; 33(5):929-36. PubMed ID: 18949355
[TBL] [Abstract][Full Text] [Related]
4. Synthetic double-stranded RNA induces multiple genes related to inflammation through Toll-like receptor 3 depending on NF-kappaB and/or IRF-3 in airway epithelial cells.
Matsukura S; Kokubu F; Kurokawa M; Kawaguchi M; Ieki K; Kuga H; Odaka M; Suzuki S; Watanabe S; Takeuchi H; Kasama T; Adachi M
Clin Exp Allergy; 2006 Aug; 36(8):1049-62. PubMed ID: 16911361
[TBL] [Abstract][Full Text] [Related]
5. The expression and function of Toll-like receptors 3 and 9 in human colon carcinoma.
Nojiri K; Sugimoto K; Shiraki K; Tameda M; Inagaki Y; Kusagawa S; Ogura S; Tanaka J; Yoneda M; Yamamoto N; Okano H; Takei Y; Ito M; Kasai C; Inoue H; Takase K
Oncol Rep; 2013 May; 29(5):1737-43. PubMed ID: 23467704
[TBL] [Abstract][Full Text] [Related]
6. A synthetic dsRNA, as a TLR3 pathwaysynergist, combined with sorafenib suppresses HCC in vitro and in vivo.
Xu YY; Chen L; Wang GL; Zhou JM; Zhang YX; Wei YZ; Zhu YY; Qin J
BMC Cancer; 2013 Nov; 13():527. PubMed ID: 24195809
[TBL] [Abstract][Full Text] [Related]
7. TLR3 signaling in a hepatoma cell line is skewed towards apoptosis.
Khvalevsky E; Rivkin L; Rachmilewitz J; Galun E; Giladi H
J Cell Biochem; 2007 Apr; 100(5):1301-12. PubMed ID: 17243100
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effect of dsRNA TLR3 agonist in a rat hepatocellular carcinoma model.
Xu YY; Chen L; Zhou JM; Wu YY; Zhu YY
Mol Med Rep; 2013 Oct; 8(4):1037-42. PubMed ID: 23970360
[TBL] [Abstract][Full Text] [Related]
9. Toll-like receptor-3-induced mitochondrial dysfunction in cultured human hepatocytes.
Djafarzadeh S; Vuda M; Takala J; Ochs M; Jakob SM
Mitochondrion; 2011 Jan; 11(1):83-8. PubMed ID: 20691286
[TBL] [Abstract][Full Text] [Related]
10. Poly I:C enhances cycloheximide-induced apoptosis of tumor cells through TLR3 pathway.
Jiang Q; Wei H; Tian Z
BMC Cancer; 2008 Jan; 8():12. PubMed ID: 18199340
[TBL] [Abstract][Full Text] [Related]
11. Double-stranded RNA induces iNOS gene expression in Schwann cells, sensory neuronal death, and peripheral nerve demyelination.
Lee H; Park C; Cho IH; Kim HY; Jo EK; Lee S; Kho HS; Choi SY; Oh SB; Park K; Kim JS; Lee SJ
Glia; 2007 May; 55(7):712-22. PubMed ID: 17348024
[TBL] [Abstract][Full Text] [Related]
12. Preferential involvement of mitochondria in Toll-like receptor 3 agonist-induced neuroblastoma cell apoptosis, but not in inhibition of cell growth.
Chuang JH; Lin TK; Tai MH; Liou CW; Huang ST; Wu CL; Lin HY; Wang PW
Apoptosis; 2012 Apr; 17(4):335-48. PubMed ID: 22187010
[TBL] [Abstract][Full Text] [Related]
13. Double-stranded RNA induces melanocyte death via activation of Toll-like receptor 3.
Yu N; Zhang S; Sun T; Kang K; Guan M; Xiang L
Exp Dermatol; 2011 Feb; 20(2):134-9. PubMed ID: 21255093
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of HBV surface antigen gene expression by a lentiviral microRNA-based system inhibits HBV replication and HCC growth.
Xiangji L; Feng X; Qingbao C; Weifeng T; Xiaoqing J; Baihe Z; Feng S; Hongyang W; Mengchao W
J Viral Hepat; 2011 Sep; 18(9):653-60. PubMed ID: 20642484
[TBL] [Abstract][Full Text] [Related]
15. TLR3 ligand induces NF-{kappa}B activation and various fates of multiple myeloma cells depending on IFN-{alpha} production.
Chiron D; Pellat-Deceunynck C; Amiot M; Bataille R; Jego G
J Immunol; 2009 Apr; 182(7):4471-8. PubMed ID: 19299748
[TBL] [Abstract][Full Text] [Related]
16. The functional expression of TLR3 in EPCs impairs cell proliferation by induction of cell apoptosis and cell cycle progress inhibition.
Yang M; Xiao Z; Lv Q; Liu X; Zhou L; Chen X; Chen M; Fang L; Xie X; Hu J
Int Immunopharmacol; 2011 Dec; 11(12):2118-24. PubMed ID: 21964048
[TBL] [Abstract][Full Text] [Related]
17. Combination of Poly I:C and arsenic trioxide triggers apoptosis synergistically via activation of TLR3 and mitochondrial pathways in hepatocellular carcinoma cells.
Shen P; Jiang T; Lu H; Han H; Luo R
Cell Biol Int; 2011 Aug; 35(8):803-10. PubMed ID: 21418039
[TBL] [Abstract][Full Text] [Related]
18. Signal regulatory protein alpha negatively regulates both TLR3 and cytoplasmic pathways in type I interferon induction.
Dong LW; Kong XN; Yan HX; Yu LX; Chen L; Yang W; Liu Q; Huang DD; Wu MC; Wang HY
Mol Immunol; 2008 Jun; 45(11):3025-35. PubMed ID: 18471880
[TBL] [Abstract][Full Text] [Related]
19. TLR3 expression correlates with apoptosis, proliferation and angiogenesis in hepatocellular carcinoma and predicts prognosis.
Yuan MM; Xu YY; Chen L; Li XY; Qin J; Shen Y
BMC Cancer; 2015 Apr; 15():245. PubMed ID: 25884709
[TBL] [Abstract][Full Text] [Related]
20. Establishment of a monoclonal antibody against human Toll-like receptor 3 that blocks double-stranded RNA-mediated signaling.
Matsumoto M; Kikkawa S; Kohase M; Miyake K; Seya T
Biochem Biophys Res Commun; 2002 May; 293(5):1364-9. PubMed ID: 12054664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
